Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling: Two Cytochrome P450 3A4 Substrates Coadministered with Ketoconazole or Verapamil

Author： Perdaems Nathalie  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.4, 2010-04, pp. : 239-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Silico Predictions and In Vivo Results of Drug–Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 364-373

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4

By Lau Wei   Gurbel Paul  

Pharmaceutical Research, Vol. 23, Iss. 12, 2006-12 ,pp. : 2691-2708

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 Part 3: Impact of Drug‐Drug Interactions

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 1, 2009-03 ,pp. : 55-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterotropic Cooperativity of Cytochrome P450 3A4 and Potential Drug-Drug Interactions

By  

Current Drug Metabolism, Vol. 2, Iss. 2, 2001-06 ,pp. : 185-198

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Metabolic Cytochrome P450 3A4 Drug-Drug Interaction between Everolimus and Azole Antifungals in a Renal Transplant Patient

By Billaud E.M.   Antoine C.  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 481-486

Adis International

Access to resources Recommend Favorite